Report : Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product (Integrated Systems, Semi-Continuous Systems, Controls); Application (End Product Manufacturing, API Manufacturing); End User (Full-Scale Manufacturing Companies, R&D Departments) and Geography
Integrated Systems Segment to Dominate Pharmaceutical Continuous Manufacturing Market During Forecast Period
According to the new market research study of “Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product (Integrated Systems, Semi-Continuous Systems, Controls); Application (End Product Manufacturing, API Manufacturing); End User (Full-Scale Manufacturing Companies, R&D Departments) and Geography,” the market is expected to reach US$ 3,064.38 million by 2027 from US$ 1,459.53 million in 2019. The market is estimated to grow with a CAGR of 9.8% from 2020 to 2027. The report highlights trends prevailing in the global pharmaceutical continuous manufacturing market and the factors driving market along with those that act as hindrances.
The pharmaceutical continuous manufacturing market, by product, is segmented into screening and diagnostics, monitoring and alerting and disease management. In 2019, the integrated systems segment accounted for the largest market share of the global pharmaceutical continuous manufacturing market. The integrated systems are expected to dominate the product segment owing to their easy availability and accessibility as well as higher adoption of these systems as compared with the semi-continuous systems and the controls. The integrated systems help build the continuous flow during manufacturing process, facilitate end-to-end integration, and improve asset utilization.
The increasing shortages of drugs and APIs in various parts of the world coupled with advantages offered by continuous manufacturing systems in ramping up the production volumes, reducing the drug costs are expected to be the major driving factors of the market. However, deep penetration of batch manufacturing systems and high capital investments for these systems are expected to restrain the growth of the market to an extent.
The pharmaceutical continuous manufacturing market majorly consists of the players such as GEA Group, Coperion GmbH, Gericke AG, Glatt GmbH, Hosokawa Micron Group, Munson Machinery Co. Inc., Powrex Corp, Thermo Fisher Scientific Inc., Freund-vector Corporation, Fette Compacting, Alexanderwerk, LEISTRITZ AG, KORSCH AG, ACG, Cadmach Machinery Co. Pvt. Ltd., and Hovione en Aesica. The companies are focused toward the adoption of organic strategies such as partnership and collaborations to sustain their position in the dynamic market. For instance, in January 2017, GEA has entered into a partnership with Siemens AG to the pharmaceutical and life sciences industry by offering an integrated continuous tablet manufacturing line.
The report analyzes pharmaceutical continuous manufacturing market on the basis of following segments:
By End User